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This Month in the Journal
This month in the Journal, Altmu¨ller et al. (p. 936) dis-
cuss the difficulties with linkage discovery in genome-
wide scans of complex disease. They created a database
of 101 of these scans, which is almost all of the scans
that had been performed as of December 2000, and an-
alyzed the success of this methodology. No single study
design is clearly better than another, and the only factors
that appear to improve the chance of success in a ge-
nomewide scan are an increase in the sample size and
an increase the homogeneity of the sample.
The other review this month, by Resendes et al. (p.
923), discusses the many different forms of hereditary
deafness and the molecular mechanisms underlying hear-
ing impairment. The genes known to be involved are nu-
merous and still increasing, and this review provides an
overview of the nature of these genes and their functions,
as well as some insight into the ways that mutations in
these genes lead to phenotypes that are sometimes quite
variable.
Identification of HumanTSIX, by Migeon et al.
(p. 951)
The transcript from the Xist gene in mice initiates the
process of X inactivation for the chromosome from
which it is transcribed. A second transcript, from the
gene Tsix, is partly antisense to the Xist transcript and
is believed to protect the active X from being shut off
by Xist. Humans also express an XIST transcript, but
no ortholog to Tsix had been identified definitively until
Migeon et al. used reverse-transcription–PCR primers
spaced across the human X-inactivation center and
found only one transcript, in addition to XIST, in this
region. The gene encoding this transcript is believed to
be the human counterpart of Tsix. It is an antisense
transcript that partially overlaps XIST, and it is ex-
pressed only in cells of fetal origin. However, TSIX is
truncated at its 5′ end relative to Tsix, it does not overlap
the XIST promoter, and it lacks the CpG island that is
crucial for Tsix function. Furthermore, there is coex-
pression of TSIX and XIST in embryo-derived cells, in-
dicating that TSIX expression does not repress XIST
expression, as has been proposed to occur in mice. An
evolutionary breakpoint appears to have shortened the
TSIX locus, compared to the mouse locus. These murine/
human differences at this locus indicate that the TSIX/
Tsix orthologs may not function in the same manner.
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Oculocutaneous Albinism 4, by Newton et al. (p. 981)
Mice that possess certain alleles in the underwhite (uw)
gene show generalized hypopigmentation. On the basis
of the phenotype of these mice, the protein encoded by
this gene appears to be a major determinant of pigmen-
tation. Other mouse strains with generalized pigmen-
tation defects have mutations in genes whose human
orthologs are mutated in people with oculocutaneous
albinism (OCA), a generalized pigmentation defect that
affects eye development and that leads to an increased
risk of skin cancer. This implicates the human ortholog
of the uw gene in OCA. Newton et al. identified one
expressed-sequence tag that was restricted to skin and
eye, tissues that contain melanocytes, in the human chro-
mosome 5p region, which is syntenic to the mouse region
containing uw. This gene, dubbed “MATP,” is mutated
in one patient with OCA, thereby defining a fourth type
of OCA, OCA4. The mutation alters a splice-acceptor
sequence and would result in the skipping of exon 2 of
MATP. A recent article in Nature Genetics (see the ref-
erence to Fukamachi et al., in Newton et al.’s article)
reported mutations of the medaka-fish ortholog of
MATP in fish with generalized hypopigmentation. Al-
though the role of the proteins encoded by these genes
is unclear, homology searches indicate that MATP is a
transporter and that it possesses a sucrose-transporter
signature sequence.
COL3A1 Null Mutations Cause EDS Type IV, by
Schwarze et al. (p. 989)
More than 200 mutations inCOL3A1, the gene encoding
the chains of type III procollagen, have been identified in
people with Ehlers-Danlos syndrome type IV (EDS type
IV). EDS type IV is a collagen-deficiency syndrome, the
most severe complications of which are spontaneous rup-
ture of the bowels and large arteries. These mutations all
lead to the synthesis of abnormal type III procollagen. It
has been speculated thatCOL3A1 haploinsufficiencymay
lead to a less severe phenotype than is seen with mutations
that produce abnormal collagen chains. Schwarze et al.
examined cells from individuals with possible and prob-
able EDS type IV, looking for the presence of COL3A1
mRNA from both alleles. Three patients showed stable
transcript from only one COL3A1 allele, owing to pre-
mature truncating codons in the other allele, whereas one
patient possessed a nonsense mutation, near the end of
the gene, that did not affect transcript stability. The de-
fective procollagen chains produced from the stable mu-
tated transcript persisted as monomers in the cells of the
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patient and therefore did not appear to be incorporated
into collagen trimers. All four mutations in this study
therefore result in protein deficiency, yet the phenotype
associated with these mutations does not differ from that
produced by mutations that lead to abnormal type III
procollagen.
Excess Twin Pairs in Autism, by Greenberg et al.
(p. 1062)
The factors, other than genetics, that influence the de-
velopment of autism are unclear. To examine twinning
as a potential risk factor for autism, Greenberg et al.
collected a sample, through the Autism Genetic Resource
Exchange, of families with exactly two autistic offspring.
The observed twinning rates in this sample were sub-
stantially different than those predicted by population
twinning rates. For this difference to be attributable to
an ascertainment bias, the authors calculate that autistic
twin pairs would have to be 11.9 times more likely than
nontwin affected sib pairs to be ascertained in the study.
A sample of diabetic families that was collected in a
similar manner did not show a significant deviation from
the expected amount of overall twinning, suggesting that
the method of sample ascertainment does not inherently
result in a sample with a high number of twins. The fact
that there is an excess of MZ twins in the autism sample
supports a genetic basis for autism, but the excess of
MZ and DZ twins in the sample suggests that risk fac-
tors related to twinning itself may contribute to autism.
Mutation Rates in the mtDNA CR, by Heyer et al.
(p. 1113)
mtDNA mutation-rate estimates derived from large ped-
igrees are much greater than those estimated from phy-
logenetic data. Heyer et al. attack this discrepancy, using
control-region sequence in deep-rooting pedigrees from
Quebec. To increase the number of transmissions ex-
amined, they combine these data with those from ped-
igrees in other studies. In addition, unrelated European
control-region sequences were gleaned, from a database,
to use in phylogenetic calculations of mutation rates.
Heyer et al. find that mutation-rate heterogeneity in the
control region can be defined by three classes of sequence
sites: those with slow, moderate, and fast mutation rates.
Sites with a fast mutation rate make up a minority of
the sites, but they are preferentially identified in pedigree
studies; on the other hand, sites that rarely show sub-
stitutions are more likely to be found in phylogenetic
studies. This work begins to reconcile the differences, in
mutation-rate estimates, between pedigree and phylo-
genetic studies, and additional data in this area should
make it possible to more accurately calibrate the mo-
lecular clock of mtDNA mutation rates.
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